FI71141C - Foerfarande foer framstaellning av nya som antibakteriella aemnen anvaendbara 6,7-dihydro-1-oxo-benzo/ij/-kinolizin-2-karboxylsyror och 1,2-dihydro-6-oxo-pyrrolo/3,2,1-ij/-kinolin-5-karboxylsyror - Google Patents

Foerfarande foer framstaellning av nya som antibakteriella aemnen anvaendbara 6,7-dihydro-1-oxo-benzo/ij/-kinolizin-2-karboxylsyror och 1,2-dihydro-6-oxo-pyrrolo/3,2,1-ij/-kinolin-5-karboxylsyror Download PDF

Info

Publication number
FI71141C
FI71141C FI813526A FI813526A FI71141C FI 71141 C FI71141 C FI 71141C FI 813526 A FI813526 A FI 813526A FI 813526 A FI813526 A FI 813526A FI 71141 C FI71141 C FI 71141C
Authority
FI
Finland
Prior art keywords
group
oxo
dihydro
compound
fluoro
Prior art date
Application number
FI813526A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI71141B (fi
FI813526L (fi
Inventor
Hirsohi Ishikawa
Testuyuki Uno
Masanobu Kano
Kazuyuki Nakagawa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55158652A external-priority patent/JPS5781486A/ja
Priority claimed from JP56063170A external-priority patent/JPS57176987A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of FI813526L publication Critical patent/FI813526L/fi
Publication of FI71141B publication Critical patent/FI71141B/fi
Application granted granted Critical
Publication of FI71141C publication Critical patent/FI71141C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI813526A 1980-11-10 1981-11-09 Foerfarande foer framstaellning av nya som antibakteriella aemnen anvaendbara 6,7-dihydro-1-oxo-benzo/ij/-kinolizin-2-karboxylsyror och 1,2-dihydro-6-oxo-pyrrolo/3,2,1-ij/-kinolin-5-karboxylsyror FI71141C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP15865280 1980-11-10
JP55158652A JPS5781486A (en) 1980-11-10 1980-11-10 Benzo(ij)quinolidine-2-carboxylic acid derivative
JP56063170A JPS57176987A (en) 1981-04-24 1981-04-24 Pyrrolo(3,2,1-ij)quinoline-5-carboxylic acid derivative
JP6317081 1981-04-24

Publications (3)

Publication Number Publication Date
FI813526L FI813526L (fi) 1982-05-11
FI71141B FI71141B (fi) 1986-08-14
FI71141C true FI71141C (fi) 1986-11-24

Family

ID=26404260

Family Applications (1)

Application Number Title Priority Date Filing Date
FI813526A FI71141C (fi) 1980-11-10 1981-11-09 Foerfarande foer framstaellning av nya som antibakteriella aemnen anvaendbara 6,7-dihydro-1-oxo-benzo/ij/-kinolizin-2-karboxylsyror och 1,2-dihydro-6-oxo-pyrrolo/3,2,1-ij/-kinolin-5-karboxylsyror

Country Status (19)

Country Link
US (2) US4399134A (ru)
KR (1) KR880001625B1 (ru)
AT (2) AT395150B (ru)
AU (1) AU546358B2 (ru)
CA (1) CA1179341A (ru)
CH (1) CH648845A5 (ru)
DE (2) DE10075035I2 (ru)
DK (1) DK160940C (ru)
ES (2) ES507493A0 (ru)
FI (1) FI71141C (ru)
FR (1) FR2493849A1 (ru)
GB (1) GB2086905B (ru)
IT (1) IT1171646B (ru)
NL (1) NL193457C (ru)
NO (1) NO156828C (ru)
PH (1) PH16685A (ru)
PT (1) PT73957B (ru)
SE (1) SE448542B (ru)
SU (2) SU1366055A3 (ru)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO156828C (no) * 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
US4380543A (en) * 1981-11-06 1983-04-19 Riker Laboratories, Inc. Antimicrobial 8-cyano-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acids
PH22140A (en) * 1982-06-29 1988-06-01 Daiichi Seiyaku Co Tricyclic compounds
US4443447A (en) * 1982-10-25 1984-04-17 Riker Laboratories, Inc. Phenyl-substituted tricyclic antibacterial agents
JPS5978189A (ja) * 1982-10-26 1984-05-04 Otsuka Pharmaceut Co Ltd ピロロ〔３，２，１−ｉｊ〕キノリン−５−カルボン酸誘導体
US4472406A (en) * 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-8-(imidazol-1-yl)-5-methyl-1-oxo-1H,5H-benzo [ij]quinolizine-2-carboxylic acids and derivatives
JPS59137482A (ja) * 1983-01-26 1984-08-07 Otsuka Pharmaceut Co Ltd ピロロ〔３，２，１，−ｉｊ〕キノリン−５−カルボン酸誘導体
JPS59155381A (ja) * 1983-02-22 1984-09-04 Kyorin Pharmaceut Co Ltd ベンゾキノリジンカルボン酸誘導体及びその製造法
US4473568A (en) * 1983-03-01 1984-09-25 Warner Lambert Company Antibacterial thiazolidine or thiomorpholine substituted quinolines
US4472407A (en) * 1983-03-17 1984-09-18 Riker Laboratories, Inc. Antimicrobial 8-alkoxy-6,7-dihydro-5-methyl-9-fluoro-1-oxo-1H,5H-benzo[ij]qu
US4562195A (en) * 1984-02-02 1985-12-31 Warner-Lambert Company Reversing amnesia with saturated tricyclic nitrogen-containing diones
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
US4550103A (en) * 1984-07-20 1985-10-29 Warner-Lambert Company Antibacterial 1-oxo-benzoquinolizine-2-carboxylic acids
CA1253154A (en) * 1985-05-24 1989-04-25 Atsushi Takagi Benzo¬ij|quinolizine-2-carboxylic acid derivatives
US5210193A (en) * 1986-01-17 1993-05-11 American Cyanamid Company Piperazine derivatives
US4940710A (en) * 1986-01-17 1990-07-10 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
US4948894A (en) * 1989-02-21 1990-08-14 American Cyanamid Company 8-fluoro and 7, 8, 10-trifluoro-9-(substituted)-6-oxo-6H-benzo-(C)quinolizine-5-carboxylic acids
KR900014383A (ko) * 1989-03-29 1990-10-23 원본미기재 피롤로퀴놀린 유도체, 이의 제조방법 및 이를 사용한 항균제
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
AU676267B2 (en) * 1993-03-10 1997-03-06 Otsuka Pharmaceutical Co., Ltd. Interleukin-1 inhibitor
EP0908181B8 (en) * 1996-05-20 2009-04-15 Otsuka Pharmaceutical Co., Ltd. Remedy for rosacea
DE19718065A1 (de) * 1997-04-29 1998-11-05 Henkel Kgaa Reinigungsmittel für nachvernetzende Polyurethan-Hotmelts
US6750224B1 (en) 1999-05-07 2004-06-15 Wockhardt Limited Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
EP2030620A1 (en) * 1999-05-07 2009-03-04 Wockhardt Limited (s)-benzoquinolizine carboxylic acids and their use as antibacterial agents
US6514986B2 (en) 2000-11-22 2003-02-04 Wockhardt Limited Chiral fluoroquinolone arginine salt forms
DE19962470A1 (de) † 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
US6608078B2 (en) * 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
WO2001085728A2 (en) * 2000-05-08 2001-11-15 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i, j] quinolizines, processes, compositions and methods of treatment
DE60131416T2 (de) * 2000-05-08 2008-09-18 Wockhardt Ltd. Chirale fluochinolon-argininsalzformen
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
JP2005511743A (ja) * 2001-12-13 2005-04-28 ウォックハート・リミテッド 新世代の三重標的化したキラルな広域スペクトラム抗菌性の７位置換ピペリジノ−キノロンカルボン酸誘導体、その調製方法、組成物、および医薬としての使用
WO2003099815A1 (en) * 2002-05-28 2003-12-04 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
EP1918289A3 (en) 2002-05-28 2009-08-19 Wockhardt Limited Crystalline nadifloxacin arginine salt form
WO2004058262A1 (en) * 2002-12-31 2004-07-15 Wockhardt Limited Benzoquinolizine-2-carboxylic acid-containing compositions
EP1578449A2 (en) * 2002-12-31 2005-09-28 Wockhardt Limited Compositions of benzoquinolizine carboxylic acid antibiotic drugs
PL214849B1 (pl) * 2003-09-04 2013-09-30 Wockhardt Ltd Tetrahydrat soli kwasu benzochinolizyno-2-karboksylowego z arginina, sposób jego wytwarzania, kompozycja zawierajaca przedmiotowy tetrahydrat soli oraz jego zastosowanie
ATE458737T1 (de) * 2005-10-21 2010-03-15 Glaxo Group Ltd Peri-kondensierte tricyclische verbindungen verwendbar als antibakterielle mittel
JP6240063B2 (ja) 2011-04-28 2017-11-29 ザ ブロード インスティテュート， インコーポレイテッド ヒストンデアセチラーゼ阻害剤
WO2014018979A1 (en) 2012-07-27 2014-01-30 The Broad Institute, Inc. Inhibitors of histone deacetylase
US9914717B2 (en) 2012-12-20 2018-03-13 The Broad Institute, Inc. Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
BR112016008378B1 (pt) 2013-10-14 2022-11-08 Eisai R&D Management Co., Ltd Compostos de quinolina seletivamente substituídos ou sal dos mesmos, e composição farmacêutica contendo os ditos compostos
WO2015057659A1 (en) 2013-10-14 2015-04-23 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793524A (fr) * 1971-12-30 1973-06-29 Riker Laboratories Inc Acides benzoquinolizine-carboxyliques et leurs derives
US4001243A (en) * 1972-11-02 1977-01-04 Riker Laboratories, Inc. Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof
US3917609A (en) * 1973-06-27 1975-11-04 Minnesota Mining & Mfg Pyrroloquinoline carboxylic acids and derivatives
JPS6019910B2 (ja) * 1979-10-11 1985-05-18 大塚製薬株式会社 ベンゾ〔ｉｊ〕キノリジン−２−カルボン酸誘導体及びその製造法
DE2953974C2 (ru) * 1978-04-12 1992-06-25 Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo, Jp
US4416884A (en) * 1978-04-12 1983-11-22 Otsuka Pharmaceutical Co., Ltd. Piperazinylbenzoheterocyclic compounds
JPS5540616A (en) * 1978-09-14 1980-03-22 Otsuka Pharmaceut Co Ltd Preparation of benzo-hetero-compound
JPS5630964A (en) * 1979-08-22 1981-03-28 Kyorin Pharmaceut Co Ltd Novel substituted quinolinecarboxylic acid and its preparation
JPS55149284A (en) * 1980-05-02 1980-11-20 Otsuka Pharmaceut Co Ltd Piperazinylbenzo heterocyclic derivative
NO156828C (no) * 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
AT380250B (de) * 1980-12-18 1986-04-25 Otsuka Pharma Co Ltd Verfahren zur herstellung benzoheterocyclischer verbindungen

Also Published As

Publication number Publication date
US4399134A (en) 1983-08-16
IT8149656A0 (it) 1981-11-09
FI71141B (fi) 1986-08-14
ATA474881A (de) 1992-02-15
DK495281A (da) 1982-05-11
CH648845A5 (de) 1985-04-15
NO813726L (no) 1982-05-11
AT395150B (de) 1992-09-25
GB2086905A (en) 1982-05-19
PT73957A (en) 1981-12-01
GB2086905B (en) 1984-12-05
DE10075035I1 (de) 2001-02-22
ES516523A0 (es) 1983-12-01
PT73957B (en) 1983-04-18
FR2493849B1 (ru) 1984-12-28
KR830007643A (ko) 1983-11-04
NL193457B (nl) 1999-07-01
ATA288789A (de) 1991-03-15
FR2493849A1 (fr) 1982-05-14
ES8301981A1 (es) 1983-02-01
NO156828B (no) 1987-08-24
DE10075035I2 (de) 2002-03-28
AU7733581A (en) 1982-08-05
KR880001625B1 (ko) 1988-09-02
ES8401035A1 (es) 1983-12-01
PH16685A (en) 1983-12-13
US4552879A (en) 1985-11-12
SU1277896A3 (ru) 1986-12-15
CA1179341A (en) 1984-12-11
SU1366055A3 (ru) 1988-01-07
NO156828C (no) 1987-12-02
DK160940C (da) 1991-10-21
AU546358B2 (en) 1985-08-29
NL193457C (nl) 1999-11-02
ES507493A0 (es) 1983-02-01
SE448542B (sv) 1987-03-02
IT1171646B (it) 1987-06-10
DE3144455C2 (ru) 1990-10-04
SE8106642L (sv) 1982-06-14
NL8105075A (nl) 1982-06-01
DK160940B (da) 1991-05-06
AT393383B (de) 1991-10-10
DE3144455A1 (de) 1982-06-24
FI813526L (fi) 1982-05-11

Similar Documents

Publication Publication Date Title
FI71141C (fi) Foerfarande foer framstaellning av nya som antibakteriella aemnen anvaendbara 6,7-dihydro-1-oxo-benzo/ij/-kinolizin-2-karboxylsyror och 1,2-dihydro-6-oxo-pyrrolo/3,2,1-ij/-kinolin-5-karboxylsyror
FI70216C (fi) Foerfarande foer framstaellning av nya 1-etyl-6-fluor-7-(3-substituerad-1-pyrrolidinyl)-1,8-naftyridin-3-karboxylsyraderivat anvaendbara som antibakteriella medel
FI66379B (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara 6-halogen-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1-substituerade 1,8-naftyridin-3-karboxylsyror och salter daerav
FI71155C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 9-halogen-7-oxo-2,3-dihydro-7h-pyrido/1,2,3-de/ /1,4/bensoxazin-6-karboxylsyraderivat
IE922099A1 (en) 7-azaisoindolinyl-quinolone- and-naphthyridonecarboxylic¹acid derivatives
HU200452B (en) Process for production of derivatives of quinoline and medical compositions containing them as active substance
JPH03193780A (ja) キノロン化合物およびその製法
US5254685A (en) Tricyclic compound or salts thereof, method for producing the same and antimicrobial agent containing the same
WO2006134491A2 (en) New crystalline form of moxifloxacin hydrochloride and process for its preparation
JP2000513378A (ja) キノロンカルボン酸誘導体
CN113227045B (zh) 取代的杂环稠合的γ-咔啉的合成
US5399553A (en) Tricyclic compound or salts thereof, method for producing the same and anti-microbial agent containing the same
IE61624B1 (en) Tricyclic compounds
KR910009331B1 (ko) 디아자비시클로아민 화합물과 그의 제조방법
EP3898581A1 (en) Substituted heterocycle fused gamma-carbolines synthesis
FI70219B (fi) Foerfarande foer framstaellning av en beta-laktamantibiotikumfoerening
EP0315827A1 (en) Derivatives of quinolinecarboxylic acid
US5556861A (en) 1,8 benzonaphthyridine derivatives and antimicrobial compositions
KR100245982B1 (ko) 신규한 퀴놀론카르복실산 유도체
JP2007536372A (ja) 微生物感染症の治療に有用なカルバミン酸エステル結合マクロライド
WO2006134608A1 (en) Gemifloxacin process and polymorphs
FI66612C (fi) Foerfarande foer framstaellning av nya saosom antimicrobica anaendbara piperazinylbensoheterocykliska foereningar
JPH08253480A (ja) １，６−ナフチリドンカルボン酸誘導体
CS235545B2 (cs) Způsob přípravy derivátů 1-ethyl nebo vinyl-6-halogen-1,4-dihydro-4- oxo-7-/1 -piperazinyl/-!,8-nafthyridinu
KR20070031900A (ko) 미생물 감염의 치료에 유용한 에스테르 연결된마크롤라이드

Legal Events

Date Code Title Description
MA Patent expired

Owner name: OTSUKA PHARMACEUTICAL CO,_. LTD.